Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00988338 · ClinicalTrials.gov registry record
Evaluation of Trinity Evolution in Patients Undergoing Foot and Ankle Fusion
A clinical trial, sponsored by Orthofix.
- Completed
- Registry status
- 106
- Enrollment target
NCT00988338 is a clinical trial that has completed, run by Orthofix. The registered enrollment target is 106 participants.
The verdict
NCT00988338 has completed, sponsored by Orthofix.
- COMPLETED
- Registry status
- 106 participants
- Enrollment target
Study Summary
The purpose of this study is to utilize Trinity Evolution as a graft source in foot/ankle fusions and to follow the subjects to measure the clinical outcomes and fusion rate. The hypothesis of the study is that Trinity Evolution will result in fusion rates and clinical outcomes similar to those obtained from autograft and other routinely used allograft materials; these include: fusion, improvement in pain, improvement in function, and absence of adverse events related to the use of the graft source.
Interventions
- BIOLOGICAL Trinity Evolution
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 106 participants |
| Start Date | 2009-09 |
| Est. Completion | 2013-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00988338
The ClinicalTrials.gov registry entry for NCT00988338 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 106 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Orthofix, which has 14 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Trinity Evolution is the first listed.
NCT00988338 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00988338 about?
NCT00988338 is a clinical study titled "Evaluation of Trinity Evolution in Patients Undergoing Foot and Ankle Fusion". The purpose of this study is to utilize Trinity Evolution as a graft source in foot/ankle fusions and to follow the subjects to measure the clinical outcomes and fusion rate. The hypothesis of the study is that Trinity Evolution will result in fusion rates and clinical outcomes similar to those obta...
What is the current status of trial NCT00988338?
This trial is currently completed. The enrollment target is 106 participants. The study started on 2009-09. Estimated completion is 2013-01.
What interventions are being tested in trial NCT00988338?
The interventions under investigation include: Trinity Evolution (BIOLOGICAL).
Who is sponsoring clinical trial NCT00988338?
This trial is sponsored by Orthofix, which has 14 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.